ID;PMID;case;DIAGNOSIS;AGE;SEX;COMORBIDITIES;SIZE (cm);SITE ;SEF_TYPE;MITOSIS/10HPF;NECROSIS;MUC4;EMA;CD34;CD31;CD99;CD45;CDK4;SMARCB1;AE1/AE3;S100;SMA;SATB2;DESMIN;MYOGENIN;STAT6;WT1;FUSION;;;;FISH_YAP1;FISH_KMT2A;FISH_EWSR;FISH_FUS;FISH_pos partner;Concurrent genomic alterations;Molecular assay/sequencing method;TREATMENT;LOCAL RECURRENCE;LR (months);DISTANT METASTASIS ;DM (months);DISEASE SPECIFIC SURVIVAL ;DSS (months);OVERALL SURVIVAL;OS (months);LFUP;LFUP (months);;167;NA;Institutional case 167;SEF;44;F;NA;1.3;D10;NA;NA;Focal;Positive;Positive;Negative;NA;NA;NA;NA;NA;Negative;Negative;NA;NA;Focal + ;NA;NA;NA;1;NA;NA;NA;NA;NA;Positive;NA;NA;NA;FISH;NA;Y;19;NA;NA;NA;NA;NA;NA;AWD;46;;168;NA;Institutional case 168;SEF;68;M;NA;15;Pelvis;NA;NA;Focal;Negative;Negative;Positive;Negative;Negative;NA;NA;NA;Positive;Negative;NA;Negative;Negative;NA;Positive;NA;1;NA;NA;NA;NA;NA;Positive;Negative;NA;NA;FISH;NA;N;NA;NA;NA;NA;NA;NA;NA;AWD;43;;169;NA;Institutional case 169;SEF;44;M;NA;7;Lung;NA;13;Absent;Positive;Negative;NA;NA;NA;NA;NA;NA;Negative;Negative;NA;Negative;NA;NA;NA;NA;1;NA;NA;NA;NA;NA;Negative;Positive;NA;NA;FISH;NA;N;NA;Y;2;NA;NA;NA;NA;AWD;37;;170;NA;Institutional case 170;Hybrid;21;F;NA;NA;groin;NA;2.00;NA;Positive;Positive;NA;NA;NA;NA;NA;NA;Negative;Negative;NA;NA;Negative;NA;NA;NA;1;NA;NA;NA;NA;NA;Negative;NA;NA;NA;FISH;NA;N;NA;N;NA;NA;NA;NA;NA;NED;37;;171;NA;Institutional case 171;SEF;56;F;NA;8;Pancreas;NA;15;Present;Negative;Positive;NA;NA;NA;NA;NA;NA;Negative;NA;NA;NA;NA;NA;NA;NA;2;NA;NA;NA;NA;NA;Negative;Negative;NA;NA;NGS;NA;Y;10;NA;NA;NA;NA;NA;NA;AWD;77;;172;NA;Institutional case 172;Hybrid;29;M;NA;7;Lung;NA;5;NA;Positive;Focal;NA;NA;NA;NA;NA;NA;Negative;Negative;NA;NA;Negative;NA;NA;NA;1;NA;NA;NA;NA;NA;NA;NA;NA;NA;FISH;NA;N;NA;Y;9;NA;NA;NA;NA;AWD;268;;173;NA;Institutional case 173;Hybrid;43;F;NA;0.4;Lung;NA;NA;NA;Positive;focal;Negative;NA;NA;NA;NA;NA;NA;Negative;NA;NA;Negative;NA;NA;NA;1;NA;NA;NA;NA;NA;NA;NA;NA;NA;FISH;NA;N;NA;N;NA;NA;NA;NA;NA;NED;36;;174;NA;Institutional case 174;SEF;62;M;NA;2.5;Pectoral region ;NA;NA;NA;NA;NA;NA;NA;NA;NEGATIVE;NA;NA;Negative;Negative;FOCAL;Negative;NA;NA;NA;NA;1;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;N;NA;N;NA;NA;NA;NA;NA;NED;679;;ID;PMID;CASE;DIAGNOSIS;AGE;SEX;COMORBIDITIES;SIZE_(cm);SITE;SEF_TYPE;MITOSIS/10HPF;NECROSIS_ptg;MUC4;EMA;CD34;CD31;CD99;CD45;CDK4;SMARCB1;AE1/AE3;S100;SMA;SATB2;DESMIN;MYOGENIN;STAT6;WT1;Fusion;Position_of_fusion_(5'-3')_breakpoint_1;Position_of_fusion_(5'-3')_breakpoint_2;RT-PCR_or_NGS_or_RNA_-Sequencing;FISH_YAP1;FISH_KMT2A;FISH_EWSR1;FISH_FUS;FISH_pos_partner;Concurrent_genomic_alterations_;Molecular_assay/sequencing_method;TREATMENT;LOCAL_RECURRENCE;LR_(Months);DISTANT__METASTASIS_;DM_(months);DISEASE_SPECIFIC_SURVIVAL_;DSS_(months);OVERALL_SURVIVAL;OS__(Months);LFUP;LFUP_(Months);;
